SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 51.59-1.1%Dec 2 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (9632)12/2/2003 10:30:15 AM
From: Icebrg  Read Replies (1) of 52153
 
>>Gotta love yahoo posters enthusiasm, that stealing 50% of viagra's share year one is possible.>>

I don't think it matters too much if it is done in one, two or three years time. The trend will be the friend of LillyIcos.

And there is one-year-ahead Europe to look at, where Cialis has taken quite a bit of the market although consumer advertising is not allowed for prescription drugs.

I believe the current share price can be defended. But also that it will stay here until the situation in the US has sorted itself out.

Apart from everything else. Lilly should buy Icos.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News